Source: FierceBiotech

Cardurion: Lawrence lands Cardurion CEO job after helping ArQule to Merck buyout

Peter Lawrence has taken up the CEO job at Cardurion Pharmaceuticals, a Takeda-partnered biotech that is moving a heart failure drug through the clinic. Lawrence landed the gig on the strength of a 14-year spell at ArQule that culminated in a $2.7 billion takeover by Merck.

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
Peter S. Lawrence's photo - President & CEO of Cardurion

President & CEO

Peter S. Lawrence

CEO Approval Rating

88/100

Read more